Proactive Infliximab Is More Effective than Vedolizumab in Inducing Fecal Calprotectin Remission in Inflammatory Bowel Disease

AuthID
P-00W-NAY
Tipo de Documento
Article in Press
Year published
2022
Publicado
in SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, ISSN: 0036-5521
Indexing
Publication Identifiers
Pubmed: 35599574
SCOPUS: 2-s2.0-85130885629
Wos: WOS:000798678000001
Source Identifiers
ISSN: 0036-5521
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.